EP1265599A4 - Composition antibiotique dotee d'inhibiteurs - Google Patents

Composition antibiotique dotee d'inhibiteurs

Info

Publication number: EP1265599A4
Authority: EP; European Patent Office
Prior art keywords: inhibitor; antibiotic composition; antibiotic; composition
Prior art date: 2000-02-24
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

EP01914484A

Other languages

German (de)

English (en)

Other versions

EP1265599A1 (fr

Inventor

Edward M Rudnic

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

MiddleBrook Pharmaceuticals Inc

Original Assignee

Advancis Pharmaceutical Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-02-24

Filing date

2001-02-23

Publication date

2006-01-18

2001-02-23 Application filed by Advancis Pharmaceutical Corp filed Critical Advancis Pharmaceutical Corp

2001-02-23 Priority claimed from PCT/US2001/005984 external-priority patent/WO2001062231A1/fr

2002-12-18 Publication of EP1265599A1 publication Critical patent/EP1265599A1/fr

2006-01-18 Publication of EP1265599A4 publication Critical patent/EP1265599A4/fr

Status Ceased legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

EP01914484A 2000-02-24 2001-02-23 Composition antibiotique dotee d'inhibiteurs Ceased EP1265599A4 (fr)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US18458200P	2000-02-24	2000-02-24
US14258200P	2000-02-24	2000-02-24
PCT/US2001/005984 WO2001062231A1 (fr)	2000-02-24	2001-02-23	Composition antibiotique dotee d'inhibiteurs
US142582P		2009-01-05

Publications (2)

Publication Number	Publication Date
EP1265599A1 EP1265599A1 (fr)	2002-12-18
EP1265599A4 true EP1265599A4 (fr)	2006-01-18

Family

ID=29586284

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP01914484A Ceased EP1265599A4 (fr)	2000-02-24	2001-02-23	Composition antibiotique dotee d'inhibiteurs

Country Status (1)

Country	Link
EP (1)	EP1265599A4 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4794001A (en) *	1986-03-04	1988-12-27	American Home Products Corporation	Formulations providing three distinct releases
EP0752850A1 (fr) *	1994-04-14	1997-01-15	Smithkline Beecham Plc	Formulation pharmaceutique

2001
- 2001-02-23 EP EP01914484A patent/EP1265599A4/fr not_active Ceased

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4794001A (en) *	1986-03-04	1988-12-27	American Home Products Corporation	Formulations providing three distinct releases
EP0752850A1 (fr) *	1994-04-14	1997-01-15	Smithkline Beecham Plc	Formulation pharmaceutique

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO0162231A1 *

Also Published As

Publication number	Publication date
EP1265599A1 (fr)	2002-12-18

Publication	Publication Date	Title
HUP0303547A3 (en)	2007-05-29	Elastomeric composition
GB0026018D0 (en)	2000-12-13	New composition
HUP0400589A3 (en)	2005-06-28	Colostrum-based composition
SG99895A1 (en)	2003-11-27	Proanthocyanidin-containing composition
HUP0303578A3 (en)	2007-05-29	Elastomeric composition
IL145793A0 (en)	2002-07-25	Odor-eliminating composition
GB0023891D0 (en)	2000-11-15	Composition
EP1270611A4 (fr)	2004-09-08	Composition
AU3986901A (en)	2001-09-03	Antibiotic composition with inhibitor
GB0109427D0 (en)	2001-06-06	Arthropod-controlling composition
IL150471A0 (en)	2002-12-01	Composition
AU2001275201A1 (en)	2001-12-11	Acne-treating composition
GB0022473D0 (en)	2000-11-01	Composition
GB0007762D0 (en)	2000-05-17	Composition
AU2001287732A1 (en)	2002-04-08	Copolycarbonate-based composition
GB0025058D0 (en)	2000-11-29	Composition
EP1265599A4 (fr)	2006-01-18	Composition antibiotique dotee d'inhibiteurs
GB0029776D0 (en)	2001-01-17	Clay composition
GB0119165D0 (en)	2001-09-26	Composition
GB0023420D0 (en)	2000-11-08	Composition
GB0008118D0 (en)	2000-05-24	Composition
GB0002320D0 (en)	2000-03-22	Composition
GB0001939D0 (en)	2000-03-22	Composition
GB0031483D0 (en)	2001-02-07	Composition
GB0029339D0 (en)	2001-01-17	Composition

Legal Events

Date	Code	Title	Description
2002-11-01	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2002-12-18	17P	Request for examination filed	Effective date: 20020824
2002-12-18	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
2002-12-18	AX	Request for extension of the european patent	Free format text: AL;LT;LV;MK;RO;SI
2006-01-18	A4	Supplementary search report drawn up and despatched	Effective date: 20051202
2006-01-18	RIC1	Information provided on ipc code assigned before grant	Ipc: A61P 31/04 20000101ALI20051128BHEP Ipc: A61K 31/545 19850101ALI20051128BHEP Ipc: A61K 31/43 19850101ALI20051128BHEP Ipc: A61K 9/54 19740701ALI20051128BHEP Ipc: A61K 9/20 19740701AFI20010905BHEP Ipc: A61K 31/424 20000101ALI20051128BHEP
2006-04-12	RAP1	Party data changed (applicant data changed or rights of an application transferred)	Owner name: ADVANCIS PHARMACEUTICAL CORPORATION
2008-10-08	RAP1	Party data changed (applicant data changed or rights of an application transferred)	Owner name: MIDDLEBROOK PHARMACEUTICALS, INC.
2008-10-29	RAP1	Party data changed (applicant data changed or rights of an application transferred)	Owner name: MIDDLEBROOK PHARMACEUTICALS, INC.
2010-04-02	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED
2010-05-05	18R	Application refused	Effective date: 20091231